Houston, TX, United States of America

Yolanda Gutierrez-Puente


Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 10(Granted Patents)


Company Filing History:


Years Active: 2010

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations in Cancer Treatment: The Contributions of Yolanda Gutierrez-Puente

Introduction

Yolanda Gutierrez-Puente, based in Houston, Texas, is an accomplished inventor whose work focuses on innovative solutions in cancer treatment. With a single patent to her name, her contributions have significant implications for the future of oncology.

Latest Patents

Yolanda holds a patent for "Small oligonucleotides with anti-tumor activity." This invention provides short antisense oligonucleotide compositions and methods for treating Bcl-2-associated diseases, such as follicular lymphoma (FL). The unique aspect of this invention lies in its use of antisense oligonucleotides that can effectively hybridize to Bcl-2 nucleic acids, a gene product known to interact with the tumorigenic protein Bcl-2. The patent outlines the use of innovative short antisense oligonucleotides, ranging from 7 to 9 bases in length, as well as specific sequences that extend to 11 or 15 bases. These compositions not only inhibit the proliferation of cancer cells when used alone but can also be combined with other antisense oligonucleotides for enhanced therapeutic effects.

Career Highlights

Yolanda Gutierrez-Puente is affiliated with the University of Texas System, where she collaborates with a dedicated team of researchers. Her commitment to developing effective treatment options for cancer has marked her career and deepened her expertise in biotechnology and therapeutic innovations.

Collaborations

Throughout her career, Yolanda has worked alongside esteemed colleagues such as Ana Maria Tari and Gabriel Lopez-Berestein. Their combined efforts highlight the importance of collaboration in advancing medical research and the development of groundbreaking treatments.

Conclusion

Yolanda Gutierrez-Puente's invention of antisense oligonucleotide compositions showcases her dedication to tackling serious health challenges like cancer. With her innovative approach and academic collaboration, she continues to push the boundaries of what is possible in cancer therapeutics, paving the way for future advancements in the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…